Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts.
about
Cell Death Conversion under Hypoxic Condition in Tumor Development and TherapyImmune Infiltration and Prostate CancerTherapeutic Lymphoid Organogenesis in the Tumor MicroenvironmentStromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic InflammationThe ever-expanding role of HIF in tumour and stromal biologyFunctional analysis implicating the SNP rs61552325 in ERBB2 as an effector for androgen-insensitive prostate cancer cell invasion.Discovery and horizontal follow-up of an autoantibody signature in human prostate cancer.Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.Stromal Myofibroblasts Are Associated with Poor Prognosis in Solid Cancers: A Meta-Analysis of Published StudiesImmunity, inflammation, and cancer: an eternal fight between good and evil.Chemokine CCL17 induced by hypoxia promotes the proliferation of cervical cancer cell.Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasisAndrogen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition.Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation.Upregulation of (C-X-C motif) Ligand 13 (CXCL13) Attenuates Morphine Analgesia in Rats with Cancer-Induced Bone Pain.Screening the key microRNAs and transcription factors in prostate cancer based on microRNA functional synergistic relationships.Inflammation and prostate cancer: friends or foe?Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.Hypoxia primes human normal prostate epithelial cells and cancer cell lines for the NLRP3 and AIM2 inflammasome activation.CC-chemokine receptor 7 is overexpressed and correlates with growth and metastasis in prostate cancer.MEK/ERK pathway is positively involved in hypoxia-induced vasculogenic mimicry formation in hepatocellular carcinoma which is regulated negatively by protein kinase A.Special Conference on Tumor Immunology and Immunotherapy: A New Chapter.A standardized herbal extract mitigates tumor inflammation and augments chemotherapy effect of docetaxel in prostate cancer.Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer.The hypoxic tumour microenvironment.Nanomaterials for cancer immunotherapy.An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel.Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia.Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.Genetics and biology of prostate cancerThe Expression of FAP in Hepatocellular Carcinoma Cells is Induced by Hypoxia and Correlates with Poor Clinical Outcomes
P2860
Q26778008-31B3CDCE-A85C-4A8F-A6E4-D25259EF2363Q26798412-15541F71-5D36-4BA2-BB84-4CBAD6521F57Q26799123-4702158D-2991-4208-8F13-3CBAFABD0DB5Q28068106-CBE8C0F2-FBCC-450D-ACE1-A4E85D6E6642Q28079015-CC324597-B351-4978-A9A5-7AE1F95D7E6BQ33779668-A073AB76-AF9E-4A77-B94A-C5872162B3CCQ35134650-175F785A-441E-474E-ABC0-A51966D96FE1Q35849866-8E4F7FB9-9C7E-4FD0-9AFA-13699E45F826Q36086002-6A4AD3FA-F406-44C5-B156-898D69CC1D9AQ36106053-7675FD3F-8EFC-4BCD-8970-F703D17A3389Q36309396-A46D5017-88DC-4764-938E-F7CF8061CE4BQ36327483-1280B023-7D20-4712-9044-922A9E74F70EQ36707740-3AFFC75D-6E01-428A-8FE3-4058F467566BQ37086004-FA0FB47B-ED90-4D77-847A-98A916C1457EQ37481670-C10181E7-CC7D-4A6C-A6B4-BC94AA6B13E2Q37582591-CF08CDAB-EC91-4D26-B4E6-E33A44857F05Q38383521-E297A5F3-C87F-4851-B4F9-56D4548C2EC3Q38707987-6DA5993D-DBB4-43A6-A207-D72C0F7AF5BBQ38779835-7511A3D8-1119-4AEE-930D-29B60A9D1CC5Q38909580-6B9FA870-E739-4505-920B-4457BB6AC047Q38930849-B89BB71E-5154-484C-9E98-636E8E9A337DQ40945758-DD38CF05-C2D6-4AF2-AC53-CC2A181725DFQ47126582-71DA2180-057D-425E-9498-3D754712954DQ47440128-68AE47F8-11EF-4392-8522-C7BA61B44F3BQ48099359-9E99BC2C-88DB-4F42-AC78-F8B270776238Q48181172-7B563998-B820-4C17-8416-B2393C868E44Q48646732-241250CC-8EA2-4E82-9A07-799B224ECAE5Q51746622-24544E30-C3B4-4FC1-B3F6-EA664B473677Q54998083-6100001E-F50F-4D50-9B0E-5AE7E23C08F0Q55247585-4C115363-1405-413F-B20D-06D0FE453C12Q57106917-A319688C-A615-4A58-9925-0F94B8F25D68Q57116792-3AC250F3-C0E7-417F-9CF6-09CFB8E6878F
P2860
Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tissue injury and hypoxia prom ...... ssion in tumor myofibroblasts.
@ast
Tissue injury and hypoxia prom ...... ssion in tumor myofibroblasts.
@en
Tissue injury and hypoxia prom ...... ssion in tumor myofibroblasts.
@nl
type
label
Tissue injury and hypoxia prom ...... ssion in tumor myofibroblasts.
@ast
Tissue injury and hypoxia prom ...... ssion in tumor myofibroblasts.
@en
Tissue injury and hypoxia prom ...... ssion in tumor myofibroblasts.
@nl
prefLabel
Tissue injury and hypoxia prom ...... ssion in tumor myofibroblasts.
@ast
Tissue injury and hypoxia prom ...... ssion in tumor myofibroblasts.
@en
Tissue injury and hypoxia prom ...... ssion in tumor myofibroblasts.
@nl
P2093
P2860
P356
P1476
Tissue injury and hypoxia prom ...... ssion in tumor myofibroblasts.
@en
P2093
Christina A M Jamieson
Massimo Ammirante
Shabnam Shalapour
Youngjin Kang
P2860
P304
14776-14781
P356
10.1073/PNAS.1416498111
P407
P577
2014-09-29T00:00:00Z